Myeloma Paper of the Day, June 13th, suggested by Robert Orlowski

Robert Orlowski shared on X:

“Myeloma Paper of the Day: Low circulating tumor cell levels (0.02% CTCs) correlate with favorable PFS and OS outcomes and distinct biological features (MGUS-like phenotype) in newly diagnosed multiple myeloma patients:”

Source: Robert Orlowski/X

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Authors: Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Evangelos Eleutherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Nikolaos Paschalidis, Maria Gavriatopoulou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Ourania E. Tsitsilonis and Evangelos Terpos

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.